FDA Inspection
Bracco Diagnostics, Inc.Bracco Diagnostics, Inc. – FDA Inspection, May 30, 2014
Record Details
This FDA Inspection record concerns Bracco Diagnostics, Inc., with an inspection on May 30, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bracco Diagnostics, Inc.
- Inspection Date
- May 30, 2014
- Product Type
- Drugs
View Company Profile
ID · 7372a10c-dbb4-4372-9b1e-0aec12879c71
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 888857
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 212.50(a)Written control procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bracco Diagnostics, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 27, 2024 | VAI | New Jersey District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
| June 5, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 13, 2013 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Bracco Diagnostics, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.